Aurora Cannabis Schedules Conference Call for Q2 2025
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), a leader in the global medical cannabis industry, has officially announced an upcoming conference call to discuss the financial results for its second quarter of 2025.
Conference Call Details
The event is set for a notable date, Wednesday, November 6, at 8:00 a.m. Eastern Time, which is 6:00 a.m. Mountain Time. On this day, the company will also release its financial results prior to the market opening, providing an essential update to investors and stakeholders.
Presenters of the Conference Call
Leading the discussion will be Miguel Martin, the Chairman and CEO of Aurora, alongside Simona King, the Chief Financial Officer. They will walk listeners through the company's performance metrics and answer any inquiries from participants.
Accessing the Webcast
A webcast link has been made available for attendees, reflecting Aurora's commitment to transparency and open communication with its investors. Moreover, this link can be found on the company’s investor relations page under the 'Events' section.
About Aurora Cannabis
Aurora is dedicated to pioneering the world of cannabis, addressing both medical and consumer markets in regions like Canada, Europe, Australia, and South America. With its headquarters in Edmonton, Alberta, the company has greatly contributed to advancements in the cannabis industry, dedicated to enhancing quality of life through innovative cannabis product offerings.
Aurora boasts an expansive adult-use brand portfolio that includes Drift, San Rafael '71, and Tasty's, along with notable medical cannabis names such as MedReleaf and CanniMed. They also maintain international brands like Pedanios and CraftPlant.
Innovations in Cannabis Products
Aurora continues to prioritize scientific research, developing high-quality products that keep them at the forefront of the industry. Through rigorous quality control measures and market innovations, the company's brands are recognized as industry leaders across medical, wellness, and recreational marijuana markets.
Sustained Growth and Industry Leadership
The company holds a significant stake in Bevo Farms Ltd., which is North America’s leading supplier of propagated agricultural plants, further bolstering its operational capabilities. Through sustained growth and a clear vision, Aurora continues to evolve and adapt within the dynamic cannabis landscape.
Frequently Asked Questions
When is the conference call for Q2 2025 results?
The conference call is scheduled for Wednesday, November 6, 2024, at 8:00 a.m. Eastern Time.
Who will host the conference call?
The conference call will be hosted by Miguel Martin, CEO, and Simona King, CFO of Aurora Cannabis Inc.
How can I access the conference call webcast?
You can access the webcast through the link provided on Aurora's Investor Relations page under the 'Events' section.
What brands does Aurora Cannabis offer?
Aurora's brand portfolio includes adult-use brands like Drift and San Rafael '71, as well as medical brands like MedReleaf and CanniMed.
Where is Aurora Cannabis headquartered?
Aurora Cannabis is headquartered in Edmonton, Alberta, Canada.
